Work

Pharmacokinetics (PK) and pharmacodynamics (PD) of SDZ PSC 833, a novel multidrug resistance reversing agent, in phase 1 trials with chemotherapeutic agents

FWCI: 0.148
Cites:
Cited by: 1
Related to: 10